Overzicht Proefschriften

Tips in using the search/filter fields

Select on a part of the content: ede	Select exactly on a certain content: =ede
Select all fields that are NOT empty: >'' (two single quotes)	Select all fields that are empty: =[spatie]
Select everything after a certain date: >31-12-2010	Select everything before a certain date: <31-12-2010
Select on a period containing the given date: >31-12-2010<1-2-2011	Type nu in a 'date' field to select everything between yesterday and tomorrow
By clicking a column title the table will be sorted on this column. If you then click the title of another column, the sort will be on this second column, preserving the first sort.
So if you want to sort on City and witghin that on Name, first click teh Name column and after that the City column. Click Reset to reset the filters and sorting.
Filters an sorting are saved and will be restored when you come back to this screen. Click Reset to reset the filters and sorting.

Displaying 1-50 of 270 results.

Titel	Promovendus	Promotor 1	Copromotor 1	Copromotor 2	Universiteit	Promotiejaar	Trefwoorden

Targeting proteostasis in atrial fibrillation	Zhang D., PhD	Henning R.H., prof. dr.	Brundel B.J.J.M., dr.		Rijksuniversiteit Groningen (RUG)	2015	Atrial fibrillation; Modelling-&-simulations;
Novel directions in therapy against age-related vascular disease	Wu H., PhD	Danser A.H.J., prof. dr.	Roks A.J.M., dr.		Erasmus Universiteit Rotterdam (EUR)	2014	Pharmacology; Cardiovascular disease;
Medication Optimization; exploring the use of a clinical decision support system	Wit H.A.J.M. de, PhD	Schols J.M.G.A., prof. dr.	Kuy P.H.M. van der, dr.	Janknegt R., PharmD PhD	Universiteit Maastricht (UM)	2016	Clinical pharmacology; Clinical rules; CDSS
Implications of the cardiomyocyte stress response on protein homeostasis in atrial fibrillation	Wiersma M., PhD	Henning R.H., prof. dr.	Brundel B.J.J.M., dr.		Rijksuniversiteit Groningen (RUG)	2016	Atrial fibrillation;
Novel protective approaches in ischemia-reperfusion injury. In vivo studies in animals and humans	Wever K.E., PhD	Rongen G.A., prof. dr.	Masereeuw R., prof. dr.	Warlé M.C., dr.	Radboud Universiteit (RU)	2012	Renal, ischemia/reperfusion injury, remote ischemic preconditioning, Annexin A5, animal and human research
The many faces of Na+, K+-ATPase: understanding the role of human isoforms in health and disease	Weigand K.M., PhD	Russel F.G.M., prof. dr.			Radboud Universiteit (RU)	2015
Determinants of treatment outcomes in epilepsy	Wassenaar M., PhD	Egberts A.C.G., prof. dr.	Leijten F.S.S., dr.	Uijl S.G., dr.	Universiteit Utrecht (UU)	2014	Epilepsy; Treatment; Treatment outcomes; Quality of life; Patient-perspectives; Clinical determinants; Seizures; Pharmacology; Daily practice; Community-based;
Reversible suppression of hemostasis in hibernation and hypothermia	Vrij E.L. de	Henning R.H., prof. dr.	Bouma H.R., PhD		Rijksuniversiteit Groningen (RUG)	2019	Hypothermia; Hibernation;
Treatment response in childhood asthma	Vijverberg S.J.H., PhD	Raaijmakers J.A.M., prof. dr.	Maitland-van der Zee A.H., prof. dr.		Universiteit Utrecht (UU)	2014	Treatment outcomes; Children; Asthma;
Preeclampsia, the renin-angiotensin-aldosterone system and beyond	Verdonk K., PhD	Danser A.H.J., prof. dr.			Erasmus Universiteit Rotterdam (EUR)	2015	Pre-eclampsia; Antihypertensive drugs; Pharmacology; Primary care; Renin-angiotensin system;
Myogenic constriction in renal failure; cause and therapy	Vavrinec P., PhD	Henning R.H., prof. dr.	Dokkum R.P.E. van, dr.	Buikema J.H., dr.	Rijksuniversiteit Groningen (RUG)	2012	renal failure myogenic constriction
The therapeutic potential of Indoleamine 2.3-dioxygenase in kidney transplantation	Vavrinacova-Yaghi D., PhD	Henning R.H., prof. dr.	Sandovici M., dr.	Seelen M.A.J., dr.	Rijksuniversiteit Groningen (RUG)	2014	Pharmacology; kidney transplantation Indoleamine 2.3-dioxygenase
Making better prescribers during a context-based pharmacotherapy learning programme	Tichelaar J., dr.	Vries Th.P.G.M. de, prof. dr. MD	Richir M.C., MD PhD		Vrije Universiteit Amsterdam (VU)	2016	pharmacotherapy; pharmacotherapy education; context based learning; clinical pharmacology; prescribing
New therapeutic targets in cardiovascular disease: focus on the renin-angiotensin system and lipid metabolism	Sun Y	Danser A.H.J., prof. dr.	Lu X., PhD		Erasmus Universiteit Rotterdam (EUR)	2020	Renin-angiotensin system; lipid metabolism; Vascular reactivity; Pharmacology; Treatment options;
Optimisation of first clinical studies in special populations: towards semi-physiological pharmacokinetics	Strougo A., PhD	Danhof M., prof. dr.	Freijer J., dr.	Yassen A., dr.	Universiteit Leiden (UL)	2015	Special-population; Model-based; PK-model; Paediatrics; Children; Hepatic and renal impairment; Semi-physiological; Population approach; PBPK;
Assessing the impact of gout:validating and understanding outcomes	Spaetgens B.P.A., dr	Boonen A.E.R.C.H., prof. dr.	Vries F. de, prof. dr.		Universiteit Maastricht (UM)	2017
Physical causes of dosing errors in patients receiving multi-infusion therapy	Snijder R.A., PhD	Egberts A.C.G., prof. dr.	Timmerman A.M.D.E., dr. ir.	Konings M.K., dr.	Universiteit Utrecht (UU)	2016	Infusion; Multi-infusion; Patient safety; Fluid mechanics; Physics; Modeling errors; Adverse events;
Shaping the pharmacokinetic landscape for renally cleared antibiotics in obesity: Studies in adults, adolescents and children	Smit C., PhD	Knibbe C.A.J., prof. dr.	Dongen H.P.A. van, dr.	Brüggemann R.J.M., PhD	Universiteit Leiden (UL)	2020	Obesity; Morbid obesity; Pharmacokinetics; Obese children; Obese adolescents; Gentamicin; Tobramycin; Aminoglycosides; Vancomycin; Renal clearance; Population pharmacokinetics; Antibiotics; Individualized dosing; Adolescents;
Biomarkers as assessment of drug efficacy in cardiovascular disease	Smink P.A., PhD	Zeeuw D. de, prof. dr.	Lambers Heerspink H.J., prof. dr.	Bakker S.J.L., prof. dr.	Rijksuniversiteit Groningen (RUG)	2013	cardiovascular disease biomarkers drug efficacy
Characterization and re-evaluation of experimental pain models in healthy subjects	Siebenga P.S	Cohen A.F., prof. dr.			Universiteit Leiden (UL)	2020	Analgesics Human evoked pain models Neuropathic pain Nociceptive pain Pharmacodynamics Phase-1 clinical triala
The alternative renin-angiotensin system: exploration of its therapeutic potential	Sevá Pessôa B., PhD	Danser A.H.J., prof. dr.	Roks A.J.M., dr.		Erasmus Universiteit Rotterdam (EUR)	2015	Pharmacology; Cardiovascular disease; Renin-angiotensin system;
Clinical pharmacological studies in tuberculosis patients	Semvua H.H., PhD	Burger D.M., prof. dr.	Aarnoutse R.E., dr.	Boeree M.J., dr.	Radboud Universiteit (RU)	2014	Clinical pharmacology; Pharmacokinetics; Tuberculosis
Learning in a student-run clinic: a new concept to improve medical education in pharmacotherapy	Schutte T., PhD	Agtmael M.A. van, prof. dr.	Richir M.C., MD PhD	Tichelaar J., dr.	Vrije Universiteit Amsterdam (VU)	2018	Pharmacotherapy education; Student-run clinic; Medical education; Workplace learning; Undergraduate education;
Pharmacy Preparations: European quality standards and regulation	Scheepers H., dr	Neef C., prof. dr.			Universiteit Maastricht (UM)	2017	Pharmacy policy;
Natriuretic peptides, diagnostics and prognostic biomarkers	Rutte J.H.W., dr.	Danser A.H.J., prof. dr.	Meiracker A.H. van den, dr.		Erasmus Universiteit Rotterdam (EUR)	2010	Antihypertensive drugs; Pharmacology; Kidney; Natriuretic peptides; Renine-angiotensine system;
Vascular Effects of Current and Novel Antimigraine Drugs	Rubio Beltrán AE	Danser A.H.J., prof. dr.	Maassen van den Brink A., dr.		Erasmus Universiteit Rotterdam (EUR)	2019	Migraine; Vascular reactivity; Drug efficacy; Pharmacology;
Bioanalysis and biotransformation of tyrosine kinase inhibitors in oncology	Rood J.J.M., PhD	Beijnen J.H., prof. dr.	Sparidans R.W., dr.		Universiteit Utrecht (UU)	2019
Early phase clinical drug development for HPV-induced disorders: novel tools and treatments	Rijsbergen M.	Burggraaf J., prof. dr.	Rissmann R, prof.dr.	Poelgeest M.I.E. van, dr.	Universiteit Leiden (UL)	2020	HPV-induced diseases;
Optmizing long-term care for hiv-infected patients in Thailand	Ramautarsing R.A., PhD	Burger D.M., prof. dr.	Wit F.W.N.M., dr.	Wijgert J.H.H.M. van de, dr.	Universiteit van Amsterdam (UvA)	2013	HIV; clinical pharmacology
Preclinical molecular imaging of target expression and target dynamics in cancer.	Pool M., PhD	Vries E.G.E. de, prof. dr.	Lub-de Hooge M.N., dr.	Terwisscha van Scheltinga A.G.T., PhD	Rijksuniversiteit Groningen (RUG)	2017
Adherence to antiretroviral combination therapy in children : what a difference half a day makes...	Piana C., PhD	Danhof M., prof. dr.	Della Pasqua O.E., dr.		Universiteit Leiden (UL)	2013	Paediatrics; Antiretroviral combination therapy; Compliance; Antiretroviral drugs; Paediatric populations; Drug combinations; Model-based; Covariate analysis; Predictive pharmacokinetic models; Clinical trial simulations; Adherence; Forgiveness of non-adherence;
Methodological approaches to the pharmacogenomics of statins	Peters B.J.M., dr.	Boer A. de, prof. dr.	Maitland-van der Zee A.H., prof. dr.	Klungel O.H., prof. dr.	Universiteit Utrecht (UU)	2010	Methodology; Statins; Pharmacogenomics;
COMPARE: Care in Oncolytic Medication surveillance:Pharmacovigilance, Acceptability, Risks and Events	Oijen B.P.C. van, dr.	Schouten H.C., prof. dr.	Kuy P.H.M. van der, dr.	Janknegt R., PharmD PhD	Universiteit Maastricht (UM)	2015	Chemotherapy; Clinical pharmacology; Pharmaceutical care;
Monitoring patients using psychotropic drugs	Nederlof M., PhD	Egberts A.C.G., prof. dr.	Heerdink E.R., dr.		Universiteit Utrecht (UU)	2018	Therapeutic drug monitoring; Biomarkers; Benefit-risk assessment; Psychotropic drugs; Psychiatry; Antidepressants; Antipsychotics
Driving-impairing medicines and traffic safety: patients' perspectives	Monteiro S.P., PhD	Gier J.J. de, prof. dr.	Dijk C.E.M.J. van, dr. ir.		Rijksuniversiteit Groningen (RUG)	2014
Aortic pathology and the role of the renin-angiotensin system	Molzer E., PhD	Danser A.H.J., prof. dr.			Erasmus Universiteit Rotterdam (EUR)	2011	Pharmacology; Cardiovascular disease; Renin-angiotensin system;
Lithium in older patients : treatment patterns and somatic adverse effects	Melick E.J.M. van, PhD	Egberts A.C.G., prof. dr.	Wilting I., dr.		Universiteit Utrecht (UU)	2014	Lithium; Older patients; Pharmacodynamics; Pharmacokinetics; Antidepressants;
Loss of proteostasis as a substrate for Atrial Fibrilation.	Meijering R.A.M., PhD	Henning R.H., prof. dr.	Brundel B.J.J.M., dr.		Rijksuniversiteit Groningen (RUG)	2014	Atrial fibrillation; Proteostasis;
Characterization of vascular 5-hydroxytryptamine, adrenergic and CGRP receptors in relation to migraine	Mehrotra S., dr.	Saxena P.R., prof. dr.	Danser A.H.J., prof. dr.	Maassen van den Brink A., dr.	Erasmus Universiteit Rotterdam (EUR)	2006	Cardiovascular disease; Pharmacology;
The role of differentiation factor 15 in diabetic kidney injury	Mazagová M., PhD	Henning R.H., prof. dr.	Deelman L.E., dr.		Rijksuniversiteit Groningen (RUG)	2012	Diabetic kidney disease; Growth differentiation factor 15;
HIV treatment: a clinical pharmacology perspective	Luin M. van, dr.	Hekster Y.A., prof. dr.	Burger D.M., prof. dr.	Richter C., dr.	Radboud Universiteit (RU)	2010	Clinical pharmacology; Pharmacokinetics; HIV; Therapeutic drug monitoring; drug-drug interactions; antiretroviral drugs
Optimizing protease inhibitor-based antiretroviral therapy for HIV-1 infected Thai adults and children	Lugt J. van der, dr.	Lange J.M.A., prof. dr.	Ananworanich J., dr.	Burger D.M., prof. dr.	Universiteit van Amsterdam (UvA)	2010	Antiretroviral; HIV; Pharmacokinetics; Clinical pharmacology; therapeutic drug monitoring
The (pro)renin receptor: moving away from prorenin?	Lu X., PhD	Danser A.H.J., prof. dr.	Meima M.E., dr.		Erasmus Universiteit Rotterdam (EUR)	2014	Cardiovascular disease; Pharmacology; Prorenin;
Comorbidities, complications and treatment of childhood obesity	Lentferink Y.E., PhD	Knibbe C.A.J., prof. dr.	Vorst M.M.J. van der, dr.		Universiteit Leiden (UL)	2019	Children; Obesity; Asthma; ADHD; Insulin resistance; Metformin; Cardiovascular diseases; Obese children; Arterial stiffness; Skin autofluorescence;
Hypertension and renal toxicity during angiogenesis inhibition: Salt dependency and treatment options	Lankhorst S.	Danser A.H.J., prof. dr.	Meiracker A.H. van den, dr.	Kappers M.H.W., PhD	Erasmus Universiteit Rotterdam (EUR)	2016	Hypertension; Renal function; Treatment options
Pharmaceutical development, preclinical research and clinical application of the bone-targeting therapeutic radiopharmaceutical rhenium-188-HEDP	Lange R., PhD	Hendrikse N.H., prof. dr.	Heine R. ter, dr.	Bloemendal H.J., dr.	Vrije Universiteit Amsterdam (VU)	2017	Radiopharmaceutics; Pharmaceutical development; Rhenium;
Neurovascular pharmacology of migraine: epigenetics and sex hormones	Labruijere S., PhD	Danser A.H.J., prof. dr.	Maassen van den Brink A., dr.		Erasmus Universiteit Rotterdam (EUR)	2014	Pharmacology; Migraine; Epigenetics; Neurovascular pharmacology;
Peripheral Projections of the Trigeminovascular System as Antimigraine Target	Labastida Ramírez A	Danser A.H.J., prof. dr.	Maassen van den Brink A., dr.		Erasmus Universiteit Rotterdam (EUR)	2019	Migraine; Vascular reactivity; Pharmacology;
Intranasal drug delivery in migraine	Kuy P.H.M. van der, dr.	Merkus F.W.H.M., prof. dr.	Lohman J.J.H.M., dr.		Universiteit Leiden (UL)	2003	Migraine; Intranasal
(Pro)renin revisited: new insights from studies in mast cells	Krop M., dr.	Danser A.H.J., prof. dr.			Erasmus Universiteit Rotterdam (EUR)	2009	Cardiovascular disease; Pharmacology; Prorenin;